289 related articles for article (PubMed ID: 34344785)
1. Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma.
Liu J; Geng W; Sun H; Liu C; Huang F; Cao J; Xia L; Zhao H; Zhai J; Li Q; Zhang X; Kuang M; Shen S; Xia Q; Wong VW; Yu J
Gut; 2022 Jun; 71(6):1203-1213. PubMed ID: 34344785
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.
Chen T; Xie G; Wang X; Fan J; Qiu Y; Zheng X; Qi X; Cao Y; Su M; Wang X; Xu LX; Yen Y; Liu P; Jia W
Mol Cell Proteomics; 2011 Jul; 10(7):M110.004945. PubMed ID: 21518826
[TBL] [Abstract][Full Text] [Related]
3. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.
Ferrarini A; Di Poto C; He S; Tu C; Varghese RS; Kara Balla A; Jayatilake M; Li Z; Ghaffari K; Fan Z; Sherif ZA; Kumar D; Kroemer A; Tadesse MG; Ressom HW
J Proteome Res; 2019 Aug; 18(8):3067-3076. PubMed ID: 31188000
[TBL] [Abstract][Full Text] [Related]
5. [High-performance liquid chromatography-mass spectrometry-based serum metabolic profiling in patients with HBV-related hepatocellular carcinoma].
Zhang L; Fan Z; Kang H; Wang Y; Liu S; Shan Z
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):49-56. PubMed ID: 30692066
[TBL] [Abstract][Full Text] [Related]
6. Plasma metabolomic profiles in liver cancer patients following stereotactic body radiotherapy.
Ng SSW; Jang GH; Kurland IJ; Qiu Y; Guha C; Dawson LA
EBioMedicine; 2020 Sep; 59():102973. PubMed ID: 32891936
[TBL] [Abstract][Full Text] [Related]
7. LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.
Xiao JF; Varghese RS; Zhou B; Nezami Ranjbar MR; Zhao Y; Tsai TH; Di Poto C; Wang J; Goerlitz D; Luo Y; Cheema AK; Sarhan N; Soliman H; Tadesse MG; Ziada DH; Ressom HW
J Proteome Res; 2012 Dec; 11(12):5914-23. PubMed ID: 23078175
[TBL] [Abstract][Full Text] [Related]
8. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study.
Stepien M; Keski-Rahkonen P; Kiss A; Robinot N; Duarte-Salles T; Murphy N; Perlemuter G; Viallon V; Tjønneland A; Rostgaard-Hansen AL; Dahm CC; Overvad K; Boutron-Ruault MC; Mancini FR; Mahamat-Saleh Y; Aleksandrova K; Kaaks R; Kühn T; Trichopoulou A; Karakatsani A; Panico S; Tumino R; Palli D; Tagliabue G; Naccarati A; Vermeulen RCH; Bueno-de-Mesquita HB; Weiderpass E; Skeie G; Ramón Quirós J; Ardanaz E; Mokoroa O; Sala N; Sánchez MJ; Huerta JM; Winkvist A; Harlid S; Ohlsson B; Sjöberg K; Schmidt JA; Wareham N; Khaw KT; Ferrari P; Rothwell JA; Gunter M; Riboli E; Scalbert A; Jenab M
Int J Cancer; 2021 Feb; 148(3):609-625. PubMed ID: 32734650
[TBL] [Abstract][Full Text] [Related]
9. Non-targeted metabolomics study for discovery of hepatocellular carcinoma serum diagnostic biomarker.
Wang S; He T; Wang H
J Pharm Biomed Anal; 2024 Feb; 239():115869. PubMed ID: 38064771
[TBL] [Abstract][Full Text] [Related]
10. Clinical and metabolomics analysis of hepatocellular carcinoma patients with diabetes mellitus.
Xia H; Chen J; Sekar K; Shi M; Xie T; Hui KM
Metabolomics; 2019 Nov; 15(12):156. PubMed ID: 31773292
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics Profiles of Hepatocellular Carcinoma in a Korean Prospective Cohort: The Korean Cancer Prevention Study-II.
Jee SH; Kim M; Kim M; Yoo HJ; Kim H; Jung KJ; Hong S; Lee JH
Cancer Prev Res (Phila); 2018 May; 11(5):303-312. PubMed ID: 29500188
[TBL] [Abstract][Full Text] [Related]
12. Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma.
Hou G; Xu W; Ding D; Tian T; Liu G; Yang Y; Liu H; Zhou W
J Gastroenterol Hepatol; 2022 Dec; 37(12):2321-2330. PubMed ID: 36208127
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.
Fan T; Rong Z; Dong J; Li J; Wang K; Wang X; Li H; Chen J; Wang F; Wang J; Wang A
Cancer Med; 2017 Oct; 6(10):2370-2384. PubMed ID: 28941178
[TBL] [Abstract][Full Text] [Related]
14. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
[TBL] [Abstract][Full Text] [Related]
15. Tissue and serum metabolomic phenotyping for diagnosis and prognosis of hepatocellular carcinoma.
Han J; Han ML; Xing H; Li ZL; Yuan DY; Wu H; Zhang H; Wang MD; Li C; Liang L; Song YY; Xu AJ; Wu MC; Shen F; Xie Y; Yang T
Int J Cancer; 2020 Mar; 146(6):1741-1753. PubMed ID: 31361910
[TBL] [Abstract][Full Text] [Related]
16. Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.
Liu SY; Zhang RL; Kang H; Fan ZJ; Du Z
World J Gastroenterol; 2013 Jun; 19(22):3423-32. PubMed ID: 23801834
[TBL] [Abstract][Full Text] [Related]
17. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
18. Global Metabolic Profiling Identifies a Pivotal Role of Proline and Hydroxyproline Metabolism in Supporting Hypoxic Response in Hepatocellular Carcinoma.
Tang L; Zeng J; Geng P; Fang C; Wang Y; Sun M; Wang C; Wang J; Yin P; Hu C; Guo L; Yu J; Gao P; Li E; Zhuang Z; Xu G; Liu Y
Clin Cancer Res; 2018 Jan; 24(2):474-485. PubMed ID: 29084919
[No Abstract] [Full Text] [Related]
19. Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients.
Li X; Yi Y; Wu T; Chen N; Gu X; Xiang L; Jiang Z; Li J; Jin H
Front Cell Infect Microbiol; 2023; 13():1170748. PubMed ID: 37260707
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
